Clinical Trial Update: Combination Study of Urelumab and Rituximab in Patients With B-cell Non-Hodgkins Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 study updating on the combination of urelumab and rituximab in patients with B-cell non-Hodgkin lymphoma, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma

Drugs mentioned

• Rituximab (rituximab)
• Urelumab (urelumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: B-Cell Malignancies | Phase 1 | Status: COMPLETED